Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
Public ClinicalTrials.gov record NCT00003160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Trial of Paclitaxel (Taxol) Administered as a Weekly One Hour Infusion in Patients With Taxol/Platinum-Refractory Stage III and IV Ovarian Cancer
Study identification
- NCT ID
- NCT00003160
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Theradex
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Interventions
- paclitaxel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 1997
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Apr 19, 2011
Started 1997
United States locations
- U.S. sites
- 18
- U.S. states
- 16
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Oncology Center at Providence Park | Mobile | Alabama | 36608 | — |
| Hematology Associates, Ltd. | Phoenix | Arizona | 85013 | — |
| Highlands Oncology Group, P.A. | Fayetteville | Arkansas | 72703 | — |
| Cancer Center of Santa Barbara | Santa Barbara | California | 93105 | — |
| Good Samaritan Medical Center | West Palm Beach | Florida | 33401 | — |
| Decatur Memorial Hospital Cancer Care Institute | Decatur | Illinois | 62526 | — |
| Creighton University Cancer Center | Omaha | Nebraska | 68131-2197 | — |
| Jersey Shore Cancer Center | Neptune City | New Jersey | 07753 | — |
| Women's Health Center at Albany Medical Center | Albany | New York | 12209 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28232-2861 | — |
| Akron General Medical Center | Akron | Ohio | 44302 | — |
| Oncology/Hematology Care, Inc. | Cincinnati | Ohio | 45219 | — |
| Cleveland Clinic Cancer Center | Cleveland | Ohio | 44195 | — |
| Women's Cancer Center of Central PA, P.C. | Harrisburg | Pennsylvania | 17105-8700 | — |
| Women and Infants Hospital of Rhode Island | Providence | Rhode Island | 02905 | — |
| Brookview Research, Inc. | Nashville | Tennessee | 37203 | — |
| Harrington Cancer Center | Amarillo | Texas | 79106 | — |
| Rockwood Clinic P.S. | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00003160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2011 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00003160 live on ClinicalTrials.gov.